How do vaccinia-vectored vaccines fit into human immunization programmes?
Ada
G L
GL
Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205.
D001500:BCG Vaccine; D005822:Genetic Vectors; D006801:Humans; D007114:Immunization / Q000379:methods*; D008458:Measles Vaccine; D010567:Pertussis Vaccine; D011054:Poliovirus Vaccine, Inactivated; D014121:Toxoids / Q000008:administration & dosage; D014612:Vaccines; D014614:Vaccines, Synthetic; D014616:Vaccinia virus; D014944:World Health Organization
D001500:BCG Vaccine; D008458:Measles Vaccine; D010567:Pertussis Vaccine; D011054:Poliovirus Vaccine, Inactivated; D014121:Toxoids; D014612:Vaccines; D014614:Vaccines, Synthetic